Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Shares of Novavax Inc. NVAX inched 0.15% higher to $13.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.45% ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

COVID-19 is a tricky virus, it changes and evolves all the time. So, as we learn in this story, we can’t let our guard down.

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...

Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...

The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...

In terms of valuation, Novavax Inc’s market capitalization stands at $2.18 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value.

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...